Publication Name	World Journal of Gastroenterology
Manuscript ID	5420
Country	Australia

Received	2013-09-06 14:21
Peer-Review Started	2013-09-06 15:53
To Make the First Decision	2013-10-29 12:29
Return for Revision	2013-10-30 11:08
Revised	2013-11-05 18:39
Second Decision	2013-12-13 13:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-12-13 14:45
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-01-08 19:54
Publish the Manuscript Online	2014-02-20 19:40

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?
Manuscript Source	Invited Manuscript
All Author List	Ian C Lawrance
Funding Agency and Grant Number
Corresponding Author	Ian C Lawrance, Professor, Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Alma Street, Fremantle, WA 6059, Australia. ian.lawrance@uwa.edu.au
Key Words	Inflammatory bowel disease; Immunosuppression; Anti-tumour necrosis factor agents; Anti-integrin; Long-term outcomes
Core Tip	Overall the physician must keep an open mind when treating inflammatory bowel disease. These patients have a long-term incurable condition than can significantly impact on all aspects of their life. Surgery does not cure the disease and thus medications may be required for many decades in order to give the patients a decent quality of life. Both the patient and the physician, therefore, need to remember the “oldies but goodies” but also keep the door open to new innovations and novel therapies.
Publish Date	2014-02-20 19:40
Citation	Lawrance IC. What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails? World J Gastroenterol 2014; 20(5): 1248-1258
URL	http://www.wjgnet.com/1007-9327/full/v20/i5/1248.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i5.1248

Full Article (PDF)	WJG-20-1248.pdf
Full Article (Word)	WJG-20-1248.doc
Manuscript File	5420-Review.doc
Answering Reviewers	5420-Answering reviewers.pdf
Copyright License Agreement	5420-Copyright assignment.pdf
Peer-review Report	5420-Peer reviews.pdf
Scientific Editor Work List	5420-Scientific editor work list.doc